These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 210944)

  • 1. Phase II study of dianhydrogalactitol in malignant glioma.
    Espana P; Wiernik PH; Walker MD
    Cancer Treat Rep; 1978 Aug; 62(8):1199-200. PubMed ID: 210944
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Finklestein JZ; Shore N; Krivit W; Hammond D; Higgins G
    Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
    [No Abstract]   [Full Text] [Related]  

  • 3. Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
    Eagan RT; Childs DS; Layton DD; Laws ER; Bisel HF; Holbrook MA; Fleming TR
    JAMA; 1979 May; 241(19):2046-50. PubMed ID: 219269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD; Baker L; Thigpen T
    Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
    Thigpen JT; Samson MK
    Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
    Vats TS; Lui V; Trueworthy R; van Eys J
    Cancer Treat Rep; 1981; 65(1-2):121-2. PubMed ID: 6939482
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
    Hahn RG; Bauer M; Wolter J; Creech R; Bennett JM; Wampler G
    Cancer Treat Rep; 1979 Mar; 63(3):513-5. PubMed ID: 371804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomas.
    Edmonson JH; Frytak S; Letendre L; Kvols LK; Eagan RT
    Cancer Treat Rep; 1979; 63(11-12):2081-3. PubMed ID: 526941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
    Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
    Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
    Thigpen JT; Al-Sarraf M; Hewlett JS
    Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1985 Jun; 69(6):713-6. PubMed ID: 3926311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
    Stehman FB; Blessing JA; Homesley HD; Currie JL; Yordan EL
    Invest New Drugs; 1984; 2(3):331-3. PubMed ID: 6511240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dianhydrogalactitol in the treatment of children with primary brain tumors.
    Weinblatt ME; Ortega JA; Giggins GR; Siegel SE
    Cancer Treat Rep; 1981; 65(9-10):923-4. PubMed ID: 7273030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observation of 15 cases of chronic myelogenous leukemia treated with 1,2,5,6-dianhydrodulcitol].
    Huang ZG
    Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):356-8. PubMed ID: 6957285
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.
    Perry MC; Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Treat Rep; 1976 Sep; 60(9):1247-50. PubMed ID: 797447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
    Haas CD; Lehane D; Bottomley R
    Med Pediatr Oncol; 1983; 11(4):281-3. PubMed ID: 6888328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
    Vogl SE; Seltzer V; Camacho F; Calanog A
    Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.